These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31496510)

  • 1. Interleukin-6, procalcitonin, and vascular endothelial growth factor in plasma and dialysate correlate with dialysis adequacy in continuous ambulatory peritoneal dialysis patients.
    Boonyarittipong M; Kurathong S; Trakarnvanich T
    Clin Nephrol; 2019 Nov; 92(5):273-275. PubMed ID: 31496510
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected growth factors in peritoneal dialysis: their relationship to markers of inflammation, dialysis adequacy, residual renal function, and peritoneal membrane transport.
    Stompór T; Zdzienicka A; Motyka M; Dembińska-Kieć A; Davies SJ; Sulowicz W
    Perit Dial Int; 2002; 22(6):670-6. PubMed ID: 12556068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate.
    Pecoits-Filho R; Araújo MR; Lindholm B; Stenvinkel P; Abensur H; Romão JE; Marcondes M; De Oliveira AH; Noronha IL
    Nephrol Dial Transplant; 2002 Aug; 17(8):1480-6. PubMed ID: 12147798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between the vascular endothelial growth factor-to-cancer antigen 125 ratio in peritoneal dialysis effluent and the epithelial-to-mesenchymal transition in continuous ambulatory peritoneal dialysis.
    Do JY; Kim YL; Park JW; Chang KA; Lee SH; Ryu DH; Kim CD; Park SH; Yoon KW
    Perit Dial Int; 2008 Jun; 28 Suppl 3():S101-6. PubMed ID: 18552237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis?
    Cueto-Manzano AM; Rojas-Campos E; Martínez-Ramírez HR; Valera-González I; Medina M; Monteón F; Ruiz N; Becerra M; Palomeque MA; Cortés-Sanabria L
    Perit Dial Int; 2006; 26(3):341-8. PubMed ID: 16722027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
    Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1993 Sep; 22(3):430-5. PubMed ID: 8372840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients.
    Oh KH; Jung JY; Yoon MO; Song A; Lee H; Ro H; Hwang YH; Kim DK; Margetts P; Ahn C
    Nephrol Dial Transplant; 2010 May; 25(5):1639-46. PubMed ID: 20061317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Icodextrin improve angiogenesis of peritoneal membrane in continuous ambulatory peritoneal dialysis patients].
    Dai HL; Lin AW; Qian JQ; Fang W; Ni ZH; Cao LO; Lin XH; Wu QW
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(40):2843-7. PubMed ID: 21162796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
    Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
    J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphism of VEGF: Impact on longitudinal change of peritoneal transport and survival of peritoneal dialysis patients.
    Szeto CC; Chow KM; Poon P; Szeto CY; Wong TY; Li PK
    Kidney Int; 2004 May; 65(5):1947-55. PubMed ID: 15086939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular calcification in continuous ambulatory peritoneal dialysis patients.
    Peride I; Checheriţă IA; Smarandache DR; Rădulescu D; Sinescu RD; Niculae A; Pricop C
    Rom J Morphol Embryol; 2015; 56(2 Suppl):777-80. PubMed ID: 26429172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control.
    Botelho C; Rodrigues A; Oliveira JC; Cabrita A
    J Nephrol; 2013; 26(1):183-90. PubMed ID: 22460184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis.
    Brauner A; Hylander B; Wretlind B
    Am J Kidney Dis; 1996 Mar; 27(3):402-8. PubMed ID: 8604710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of effluent markers cancer antigen 125, vascular endothelial growth factor, and interleukin-6: relationship with peritoneal transport.
    Rodrigues A; Martins M; Santos MJ; Fonseca I; Oliveira JC; Cabrita A; Melo e Castro J; Krediet RT
    Adv Perit Dial; 2004; 20():8-12. PubMed ID: 15384786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal dialysis adequacy and risk of death.
    Rocco M; Soucie JM; Pastan S; McClellan WM
    Kidney Int; 2000 Jul; 58(1):446-57. PubMed ID: 10886593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gastric emptying in patients with chronic renal failure on continuous ambulatory peritoneal dialysis using 99mTc-solid meal.
    Hubalewska A; Stompór T; Płaczkiewicz E; Staszczak A; Huszno B; Sułowicz W; Szybiński Z
    Nucl Med Rev Cent East Eur; 2004; 7(1):27-30. PubMed ID: 15318307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6 levels decrease in effluent from patients dialyzed with bicarbonate/lactate-based peritoneal dialysis solutions.
    Cooker LA; Luneburg P; Holmes CJ; Jones S; Topley N;
    Perit Dial Int; 2001; 21 Suppl 3():S102-7. PubMed ID: 11887802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reduction in the incidence of peritonitis in continuous ambulatory peritoneal dialysis using a simple microbiological dialysate-check].
    Oliveri M; Záruba K
    Schweiz Rundsch Med Prax; 1982 Oct; 71(43):1696-1700. PubMed ID: 7188555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.